BioSpace News Archive

ASPiRA LABS, a Vermillion company today announced it has entered into an agreement with BlueCross BlueShield of Illinois.

Kite announced it has entered into a clinical trial collaboration with Pfizer Inc. to evaluate the safety and efficacy of the investigational combination of Yescarta (axicabtagene ciloleucel) and Pfizer’s utomilumab, a fully humanized 4-1BB agonist monoclonal antibody, in patients with refractory large B-cell lymphoma.

Arrowhead Pharmaceuticals announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock, offered at a price of $5.25 per share, before underwriting discounts.

To date, five patients with TNBC have been treated with a single cycle of ImmunoPulse IL-12.

Alligator Bioscience announced today the appointment of Anu Balendran, PhD, as VP Business Development.

Martin Koch comes to Inotrem with more than 25 years of experience in the healthcare industry.

ERS Genomics announced that yesterday, the European Patent Office revoked in its entirety the first of several Broad Institute patents that are facing opposition there.

Enrollment of subjects has started for the IND opening study, which will test single and multiple doses of a solid-dose formulation of BHV-5000 in healthy volunteers.

A conference call is planned for Thursday, February 1, at 15:00 CET / 9:00 EST hosted by Peer M. Schatz, CEO, and Roland Sackers, CFO.

The inventors are Bruce McCormick, President of SAVSU Technologies, and Mike Rice, CEO of BioLife Solutions.